Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10
- PMID: 15140584
- DOI: 10.1016/j.thromres.2004.03.004
Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10
Abstract
Background: Low-dose oral vitamin K effectively returns an international normalized ratio (INR) between 4.5 and 10.0 to an INR of 2.0-3.0 within 24 h in about 70% of patients. However, the efficacy of oral vitamin K for the treatment of higher INR values has only been studied in one small randomized trial. Treatment of markedly prolonged INR values with low-dose oral vitamin K is attractive because it has the potential to greatly simplify the management of such patients.
Methods: In our tertiary care anticoagulation clinic patients with an INR of more than 10 were managed as outpatients with simple warfarin withdrawal and, where feasible, low-dose (2 mg) oral vitamin K. Only patients with additional complications such as bleeding or unexplained symptoms were admitted to hospital.
Results: Eighty-five patients had 89 episodes of an INR value of more than 10.0. Fourteen patients were admitted to the hospital for management. In the other 75 episodes patients were managed as outpatients by warfarin withdrawal. In 24 episodes patients did not receive vitamin K. In 51 episodes patients were also given oral vitamin K. None of the patients given oral vitamin K experienced bleeding requiring medical intervention (95% confidence interval (CI) 0-6%). In contrast there were three clinically important bleeding episodes amongst the patients managed with simple warfarin withdrawal (95% CI 0-34%). Patients given vitamin K were also more likely to have an INR<5 by day 3 than those managed by withdrawal of warfarin alone. Two patients admitted to hospital and given intravenous vitamin K at higher doses became temporarily refractory to anticoagulation while there were no such complications in those treated with low-dose oral vitamin K.
Conclusion: Low-dose (2 mg) oral vitamin K, coupled with temporary warfarin discontinuation, appears to be a safe and effective treatment for severe warfarin associated coagulopathy in non-bleeding patients.
Copyright 2004 Elsevier Ltd.
Similar articles
-
Low-dose oral vitamin K reliably reverses over-anticoagulation due to warfarin.Thromb Haemost. 1998 Jun;79(6):1116-8. Thromb Haemost. 1998. PMID: 9657434 Clinical Trial.
-
Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial.Lancet. 2000 Nov 4;356(9241):1551-3. doi: 10.1016/S0140-6736(00)03125-1. Lancet. 2000. PMID: 11075768 Clinical Trial.
-
Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.Pharmacotherapy. 2013 Nov;33(11):1136-46. doi: 10.1002/phar.1343. Epub 2013 Aug 22. Pharmacotherapy. 2013. PMID: 24038412
-
The use of vitamin K in patients on anticoagulant therapy: a practical guide.Am J Cardiovasc Drugs. 2004;4(1):43-55. doi: 10.2165/00129784-200404010-00005. Am J Cardiovasc Drugs. 2004. PMID: 14967065 Review.
-
Reversal of asymptomatic over-anticoagulation by orally administered vitamin K.Br J Haematol. 2006 May;133(3):331-6. doi: 10.1111/j.1365-2141.2006.06029.x. Br J Haematol. 2006. PMID: 16643436 Review.
Cited by
-
Comparative Stability of Oral Vitamin K Liquids Stored in Refrigerated Amber Plastic Syringes.J Pharm Technol. 2019 Jun;35(3):105-109. doi: 10.1177/8755122519838848. Epub 2019 Mar 29. J Pharm Technol. 2019. PMID: 34861015 Free PMC article.
-
Warfarin Re-initiation Gone Awry: A Case of Inadvertent Overdose Mandating Critical INR Management.Can J Hosp Pharm. 2015 Mar-Apr;68(2):161-7. doi: 10.4212/cjhp.v68i2.1443. Can J Hosp Pharm. 2015. PMID: 25964689 Free PMC article. No abstract available.
-
Reversing vitamin K antagonists: making the old new again.Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):605-611. doi: 10.1182/asheducation-2016.1.605. Hematology Am Soc Hematol Educ Program. 2016. PMID: 27913535 Free PMC article. Review.
-
Effect of Some Risk Factors on Over-Anticoagulation Disorders and Bleeding in Patients Receiving Anticoagulant Therapy with Overdosage of Vitamin K Antagonist.Vasc Health Risk Manag. 2023 Oct 18;19:663-672. doi: 10.2147/VHRM.S410497. eCollection 2023. Vasc Health Risk Manag. 2023. PMID: 37872943 Free PMC article.
-
Warfarinized Patients with Proximal Femoral Fractures: Survey of UK Clinical Practice.Eur J Trauma Emerg Surg. 2009 Jun;35(3):287. doi: 10.1007/s00068-008-8070-4. Epub 2008 Nov 3. Eur J Trauma Emerg Surg. 2009. PMID: 26814906
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical